Prenaissance - CALCIUM CITRATE, IRON PENTACARBONYL, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, DOCUSATE SODIUM and DOCONEXENT
Navigation:
NDC >
Supplier starting with: A > ACELLA PHARMACEUTICALS, LLC
Field |
Value |
NDC Code: |
42192-341 |
Proprietary Name: |
Prenaissance |
Suffix: |
|
Non-Proprietary Name: |
CALCIUM CITRATE, IRON PENTACARBONYL, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, DOCUSATE SODIUM and DOCONEXENT |
Dosage Form: |
CAPSULE, LIQUID FILLED |
Method: |
ORAL |
Original Marketing Date: |
19-05-2011 |
Category Name: |
UNAPPROVED DRUG OTHER |
Application Number: |
|
Labeler: |
ACELLA PHARMACEUTICALS, LLC |
Substance Name: |
.ALPHA.-TOCOPHEROL, D-; ASCORBIC ACID; CHOLECALCIFEROL; DOCONEXENT; DOCUSATE SODIUM; FERROUS FUMARATE; FOLIC ACID; PYRIDOXINE HYDROCHLORIDE; TRICALCIUM PHOSPHATE |
Active Numerator Strength: |
30; 28; 800; 325; 55; 29; 1.25; 25; 160 |
Active Ingredient Unit: |
[iU]/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1 |
Pharm Classes: |
Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],Vitamin D [Chemical/Ingredient],Vitamin D [EPC] |
DEA Schedule: |
|